General Information of the Cell Line
Cell Line ID
CL000341
Cell Line Name
WIL2
Synonyms
WIL-2
Wil.2
WI-L2
Wi-L2
Category
Transformed cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_6544
Tissue Information
Spleen
Disease
Hereditary spherocytosis (NCIt: C97074)
Hereditary spherocytosis (ORDO: Orphanet_822)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT01651, Dihydrofolate reductase
Compound ID Compound Name Compound Formula
CP0036197
2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic acid
   Show/Hide
C20H22N8O5
 2
1
IC50 = 3.8 nM
   TI
   LI
   LO
   TS
2
IC50 = 24 nM
   TI
   LI
   LO
   TS
CP0805382
2-(4-((2,4-diamino-5-chloroquinazolin-6-yl)methylamino)benzamido)pentanedioic acid
   Show/Hide
C21H21ClN6O5
 1
1
IC50 = 3.8 nM
   TI
   LI
   LO
   TS
CP0434649
2-{4-[(2,4-Diamino-quinazolin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid
   Show/Hide
C22H24N6O5
 1
1
IC50 = 3.9 nM
   TI
   LI
   LO
   TS
CP0672452
2-(4-((2,4-diamino-5-methylquinazolin-6-ylamino)methyl)benzamido)pentanedioic acid
   Show/Hide
C22H24N6O5
 1
1
IC50 = 4.1 nM
   TI
   LI
   LO
   TS
CP0056680
2-{4-[(2,4-Diamino-quinazolin-6-ylmethyl)-amino]-benzoylamino}-pentanedioic acid
   Show/Hide
C21H22N6O5
 1
1
IC50 = 4.5 nM
   TI
   LI
   LO
   TS
CP0507634
2-(4-{[(2,4-Diamino-quinazolin-6-yl)-methyl-amino]-methyl}-benzoylamino)-pentanedioic acid
   Show/Hide
C22H24N6O5
 1
1
IC50 = 4.6 nM
   TI
   LI
   LO
   TS
CP0867763
2-(4-{[(2,4-Diamino-quinazolin-6-yl)-prop-2-ynyl-amino]-methyl}-benzoylamino)-pentanedioic acid
   Show/Hide
C24H24N6O5
 1
1
IC50 = 5.3 nM
   TI
   LI
   LO
   TS
CP0887123
2-(4-{[Allyl-(2,4-diamino-quinazolin-6-yl)-amino]-methyl}-benzoylamino)-pentanedioic acid
   Show/Hide
C24H26N6O5
 1
1
IC50 = 5.4 nM
   TI
   LI
   LO
   TS
CP0378548
2-(4-{[(2,4-Diamino-quinazolin-6-yl)-formyl-amino]-methyl}-benzoylamino)-pentanedioic acid
   Show/Hide
C22H22N6O6
 1
1
IC50 = 5.7 nM
   TI
   LI
   LO
   TS
CP0163000
2-{4-[(2,4-Diamino-quinazolin-6-ylmethyl)-formyl-amino]-benzoylamino}-pentanedioic acid
   Show/Hide
C22H22N6O6
 1
1
IC50 = 5.8 nM
   TI
   LI
   LO
   TS
CP0395506
2-{4-[(2,4-Diamino-quinazolin-6-ylamino)-methyl]-benzoylamino}-pentanedioic acid
   Show/Hide
C21H22N6O5
 1
1
IC50 = 8.6 nM
   TI
   LI
   LO
   TS
CP0080967
2-{4-[(2-Amino-4-hydroxy-quinazolin-6-ylmethyl)-formyl-amino]-benzoylamino}-pentanedioic acid
   Show/Hide
C22H21N5O7
 1
1
IC50 = 11 nM
   TI
   LI
   LO
   TS
CP0053031
4-Aminofolic acid
   Show/Hide
C19H20N8O5
 1
1
IC50 = 25 nM
   TI
   LI
   LO
   TS
CP0525400
3-(4-Carboxy-4-{4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-butyrylamino)-benzene m-boronalide(methotrexate gama-(m-boronalide))
   Show/Hide
C26H28BN9O6
 1
1
IC50 = 30 nM
   TI
   LI
   LO
   TS
CP0545101
3-(4-Carboxy-4-{4-[(2,4-diamino-pteridin-6-ylmethyl)-amino]-benzoylamino}-butyrylamino)-benzoic acid
   Show/Hide
C26H25N9O6
 1
1
IC50 = 32 nM
   TI
   LI
   LO
   TS
CP0040464
2-{4-[(2-Amino-4-hydroxy-quinazolin-6-ylmethyl)-amino]-benzoylamino}-pentanedioic acid
   Show/Hide
C21H21N5O6
 1
1
IC50 = 34 nM
   TI
   LI
   LO
   TS
CP0424299
3-(4-Carboxy-4-{4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-butyrylamino)-benzoic acid
   Show/Hide
C27H27N9O6
 1
1
IC50 = 35 nM
   TI
   LI
   LO
   TS
CP0064255
2-{4-[(2-Amino-4-hydroxy-quinazolin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid
   Show/Hide
C22H23N5O6
 1
1
IC50 = 83 nM
   TI
   LI
   LO
   TS
CP0913490
2-{4-[(2-Amino-5-chloro-4-hydroxy-quinazolin-6-ylamino)-methyl]-benzoylamino}-pentanedioic acid
   Show/Hide
C21H20ClN5O6
 1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0760762
SID144917
   Show/Hide
C21H21N5O6
 1
1
IC50 = 110 nM
   TI
   LI
   LO
   TS
CP0688707
2-(4-((2-amino-4-hydroxyquinazolin-6-yl)methoxy)benzamido)pentanedioic acid
   Show/Hide
C21H20N4O7
 1
1
IC50 = 170 nM
   TI
   LI
   LO
   TS
CP0111452
Kibdelomycin
   Show/Hide
C44H60Cl2N4O14
 1
1
IC50 = 210 nM
   TI
   LI
   LO
   TS
CP0359406
2-[[4-[[(2-amino-4-oxo-3H-pyrido[2,3-d]pyrimidin-6-yl)-methylamino]methyl]benzoyl]amino]pentanedioic acid
   Show/Hide
C35H56N6O6
 1
1
IC50 = 250 nM
   TI
   LI
   LO
   TS
CP0920223
2-(4-{[(2-Amino-4-hydroxy-quinazolin-6-yl)-formyl-amino]-methyl}-benzoylamino)-pentanedioic acid
   Show/Hide
C22H21N5O7
 1
1
IC50 = 280 nM
   TI
   LI
   LO
   TS
CP0853666
2-(4-{[(2-Amino-4-hydroxy-quinazolin-6-yl)-methyl-amino]-methyl}-benzoylamino)-pentanedioic acid
   Show/Hide
C22H23N5O6
 1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
CP0686586
2-(4-((2-amino-4-hydroxyquinazolin-6-yl)methylthio)benzamido)pentanedioic acid
   Show/Hide
C21H20N4O6S
 1
1
IC50 = 330 nM
   TI
   LI
   LO
   TS
CP0672453
2-{4-[(2-Amino-4-hydroxy-5-methyl-quinazolin-6-ylamino)-methyl]-benzoylamino}-pentanedioic acid
   Show/Hide
C22H23N5O6
 1
1
IC50 = 460 nM
   TI
   LI
   LO
   TS
CP0039203
US9422297, PDDF
   Show/Hide
C24H23N5O6
 1
1
IC50 = 910 nM
   TI
   LI
   LO
   TS
CP0881005
2-(4-{[Allyl-(2-amino-4-hydroxy-quinazolin-6-yl)-amino]-methyl}-benzoylamino)-pentanedioic acid
   Show/Hide
C24H25N5O6
 1
1
IC50 = 1400 nM
   TI
   LI
   LO
   TS
CP0154254
2-[[4-[[(2-amino-4-oxo-3H-pyrido[2,3-d]pyrimidin-6-yl)-formylamino]methyl]benzoyl]amino]pentanedioic acid
   Show/Hide
C14H13N3O3S
 1
1
IC50 = 1950 nM
   TI
   LI
   LO
   TS
CP0859541
2-(4-{[(2-Amino-4-hydroxy-quinazolin-6-yl)-prop-2-ynyl-amino]-methyl}-benzoylamino)-pentanedioic acid
   Show/Hide
C24H23N5O6
 1
1
IC50 = 3000 nM
   TI
   LI
   LO
   TS
CP0886430
2-(4-{[(2-Amino-4-hydroxy-5-methyl-quinazolin-6-yl)-methyl-amino]-methyl}-benzoylamino)-pentanedioic acid
   Show/Hide
C23H25N5O6
 1
1
IC50 = 3200 nM
   TI
   LI
   LO
   TS
CP0049207
(S)-2-{4-[3-(2,4-Diamino-6-oxo-1,6-dihydro-pyrimidin-5-yl)-propylamino]-benzoylamino}-pentanedioic acid
   Show/Hide
C19H24N6O6
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0064156
(DDATHF) 5,10-Dideazatetrahydrofolic acid2-{4-[2-(2-Amino-4-oxo-3,4,5,6,7,8-hexahydro-pyrido[2,3-d]pyrimidin-6-yl)-ethyl]-benzoylamino}-pentanedioic acid
   Show/Hide
C21H25N5O6
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0046656
(2S)-2-[(4-{[(2-amino-4-oxo-1,4-dihydroquinazolin-6-yl)methyl](prop-2-yn-1-yl)amino}phenyl)formamido]pentanedioic acid
   Show/Hide
C24H23N5O6  1
1
IC50 = 440 nM
   TI
   LI
   LO
   TS
CP0394523
(2S)-2-[[(2S)-4-carboxy-2-[[4-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]benzoyl]amino]pentanoyl]amino]pentanedioic acid
   Show/Hide
C31H33N5O9  1
1
IC50 = 500 nM
   TI
   LI
   LO
   TS
CP0412173
(S)-2-((S)-4-Carboxy-4-{4-[(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-prop-2-ynyl-amino]-benzoylamino}-butyrylamino)-pentanedioic acid
   Show/Hide
C30H31N5O9  1
1
IC50 = 74 nM
   TI
   LI
   LO
   TS
CP0448983
(2S)-2-[[(2S)-4-carboxy-2-[[2-fluoro-4-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]benzoyl]amino]butanoyl]-methylamino]pentanedioic acid
   Show/Hide
C31H32FN5O9  1
1
IC50 = 440 nM
   TI
   LI
   LO
   TS
CP0453345
(4S)-5-[carboxymethyl(methyl)amino]-4-[[4-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]benzoyl]amino]-5-oxopentanoic acid
   Show/Hide
C28H29N5O7  1
1
IC50 = 330 nM
   TI
   LI
   LO
   TS
CP0457012
(2S)-2-[[(2S)-4-carboxy-2-[[2-fluoro-4-[methyl-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino]benzoyl]amino]butanoyl]-methylamino]pentanedioic acid
   Show/Hide
C29H32FN5O9  1
1
IC50 = 2300 nM
   TI
   LI
   LO
   TS
CP0459333
(2S)-2-[[(2S)-4-carboxy-4-methyl-2-[[4-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]benzoyl]amino]pentanoyl]amino]pentanedioic acid
   Show/Hide
C32H35N5O9  1
1
IC50 = 370 nM
   TI
   LI
   LO
   TS
CP0460988
(2S)-2-[[(2S)-4-carboxy-2-[[4-[(2,7-dimethyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]benzoyl]amino]butanoyl]-methylamino]pentanedioic acid
   Show/Hide
C32H35N5O9  1
1
IC50 = 640 nM
   TI
   LI
   LO
   TS
CP0510624
(2S)-2-[[(2S)-4-carboxy-2-[[4-[(2,7-dimethyl-4-oxo-3H-quinazolin-6-yl)methyl-methylamino]benzoyl]amino]butanoyl]-methylamino]pentanedioic acid
   Show/Hide
C30H35N5O9  1
1
IC50 = 800 nM
   TI
   LI
   LO
   TS
CP0514962
(2S)-2-[[(2S)-4-carboxy-2-[[4-[(2,7-dimethyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-2-fluorobenzoyl]amino]butanoyl]-methylamino]pentanedioic acid
   Show/Hide
C32H34FN5O9  1
1
IC50 = 350 nM
   TI
   LI
   LO
   TS
CP0530002
(4S)-5-(2-carboxypropan-2-ylamino)-4-[[4-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]benzoyl]amino]-5-oxopentanoic acid
   Show/Hide
C29H31N5O7  1
1
IC50 = 310 nM
   TI
   LI
   LO
   TS
CP0535306
(2S)-2-[[(2S)-4-carboxy-2-[[4-[(2,7-dimethyl-4-oxo-3H-quinazolin-6-yl)methyl-methylamino]-2-fluorobenzoyl]amino]butanoyl]-methylamino]pentanedioic acid
   Show/Hide
C30H34FN5O9  1
1
IC50 = 630 nM
   TI
   LI
   LO
   TS
CP0683934
(R)-2-((S)-4-Carboxy-4-{4-[(2,7-dimethyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-prop-2-ynyl-amino]-2-fluoro-benzoylamino}-butyrylamino)-pentanedioic acid TFA
   Show/Hide
C33H33F4N5O11  2
1
IC50 = 93 nM
   TI
   LI
   LO
   TS
2
IC50 = 170 nM
   TI
   LI
   LO
   TS
CP0719695
(R)-2-((S)-4-Carboxy-4-{4-[(2,7-dimethyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-prop-2-ynyl-amino]-2-fluoro-benzoylamino}-butyrylamino)-hexanedioic acid TFA
   Show/Hide
C34H35F4N5O11  2
1
IC50 = 190 nM
   TI
   LI
   LO
   TS
2
IC50 = 300 nM
   TI
   LI
   LO
   TS
CP0861557
(R)-2-((S)-4-Carboxy-4-{4-[(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-prop-2-ynyl-amino]-benzoylamino}-butyrylamino)-pentanedioic acid TFA
   Show/Hide
C32H32F3N5O11  1
1
IC50 = 150 nM
   TI
   LI
   LO
   TS
CP0880586
(S)-4-((R)-1-Carboxy-ethylcarbamoyl)-2-{4-[(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-prop-2-ynyl-amino]-benzoylamino}-butyric acid TFA
   Show/Hide
C30H30F3N5O9  1
1
IC50 = 150 nM
   TI
   LI
   LO
   TS
CP0900296
(R)-2-((S)-4-Carboxy-4-{4-[(2,7-dimethyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-methyl-amino]-benzoylamino}-butyrylamino)-pentanedioic acid TFA
   Show/Hide
C31H34F3N5O11  1
1
IC50 = 280 nM
   TI
   LI
   LO
   TS
CP0907047
(S)-2-((S)-4-Carboxy-4-{4-[(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-prop-2-ynyl-amino]-benzoylamino}-butyrylamino)-pentanedioic acid TFA
   Show/Hide
C32H32F3N5O11  1
1
IC50 = 2400 nM
   TI
   LI
   LO
   TS
CP0914242
(R)-2-((S)-4-Carboxy-4-{4-[(2,7-dimethyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-prop-2-ynyl-amino]-benzoylamino}-butyrylamino)-pentanedioic acid TFA
   Show/Hide
C33H34F3N5O11  1
1
IC50 = 230 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line